MedTrace Logo

Conscious Sedation for Epilepsy Surgery

NCT02988050 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-10-09

Study results available
· View outcomes & findings →

Summary

Sixty patients were randomly allocated into two groups, group PD and group PR, thirty patients in each group. Patients in PD group received propofol and dexmedetomidine intravenous infusion and patients in PR group received propofol and remifentanil intravenous infusion. Sedation score and patients' satisfaction, surgeon satisfaction, heart rate, mean arterial blood pressure, oxygen saturation, and side effects such as respiratory depression, nausea, vomiting, airway obstruction, and oxygen desaturation were recorded.

Conditions

Interventions

DRUG

Remifentanil

Remifentanil used for conscious sedation.

DRUG

Dexmedetomidine

Dexmedetomidine used for conscious sedation.

DRUG

Propofol

Used for conscious sedation.

DRUG

Bupivacaine

Local anaesthetics

DRUG

Lidocaine

Local anaesthetic

DRUG

Epinephrine

With local anaesthetic for skin infiltration.

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-02-29
Completion
2016-04-30

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02988050 on ClinicalTrials.gov